Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.
Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infections : a prospective study